Free Trial

Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership

Centessa Pharmaceuticals logo
$21.81 -0.86 (-3.79%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$21.66 -0.15 (-0.71%)
As of 09/12/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.09%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5.87M
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$17.13M
Get CNTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNTA Insider Buying and Selling by Quarter

Centessa Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/10/2025Tia L BushCTOSell25,000$22.00$550,000.00  
9/9/2025Iqbal J HussainGeneral CounselSell20,000$20.01$400,200.00  
9/9/2025Mario Alberto AccardiInsiderSell7,000$20.00$140,000.00  
9/9/2025Tia L BushCTOSell24,792$20.00$495,840.00  
8/15/2025Iqbal J HussainGeneral CounselSell6,000$17.23$103,380.00  
7/29/2025Mario Alberto AccardiInsiderSell8,322$15.23$126,744.06  
7/25/2025Gregory M WeinhoffInsiderSell10,000$15.56$155,600.00  
7/21/2025Saurabh SahaCEOSell55,000$15.92$875,600.00  
6/25/2025Gregory M WeinhoffInsiderSell10,000$13.86$138,600.00  
6/24/2025Iqbal J HussainGeneral CounselSell12,000$14.02$168,240.00  
6/24/2025Mario Alberto AccardiInsiderSell15,000$14.00$210,000.00  
6/20/2025Saurabh SahaCEOSell55,000$12.63$694,650.00  
5/27/2025Gregory M WeinhoffInsiderSell10,000$12.82$128,200.00  
5/20/2025Saurabh SahaCEOSell55,000$12.71$699,050.00  
5/16/2025Arjun GoyalDirectorBuy417,646$12.73$5,316,633.58  
5/15/2025Arjun GoyalDirectorBuy44,939$12.24$550,053.36  
5/1/2025Iqbal J HussainGeneral CounselSell311$14.00$4,354.00  
4/28/2025Iqbal J HussainGeneral CounselSell2,080$14.01$29,140.80  
4/25/2025Gregory M WeinhoffInsiderSell11,742$13.61$159,808.62  
4/25/2025Iqbal J HussainGeneral CounselSell3,609$14.00$50,526.00  
4/21/2025Saurabh SahaCEOSell14,656$12.29$180,122.24  
3/25/2025Gregory M WeinhoffInsiderSell10,000$16.34$163,400.00  
3/20/2025Saurabh SahaCEOSell55,000$16.69$917,950.00  
3/17/2025David M ChaoInsiderSell7,000$17.17$120,190.00  
3/17/2025Iqbal J HussainGeneral CounselSell6,000$16.45$98,700.00  
2/20/2025Saurabh SahaCEOSell55,000$15.93$876,150.00  
2/18/2025Iqbal J HussainGeneral CounselSell6,000$16.18$97,080.00  
2/10/2025Karen M AndersonInsiderSell429$18.99$8,146.71  
2/7/2025Karen M AndersonInsiderSell30,526$19.03$580,909.78  
2/3/2025Karen M AndersonInsiderSell6,471$16.86$109,101.06  
2/3/2025Tia L BushCTOSell11,000$16.86$185,460.00  
1/27/2025Gregory M WeinhoffInsiderSell11,742$16.47$193,390.74  
1/21/2025Saurabh SahaCEOSell55,000$15.77$867,350.00  
1/15/2025Iqbal J HussainGeneral CounselSell6,000$15.29$91,740.00  
12/26/2024Gregory M WeinhoffInsiderSell10,000$17.04$170,400.00  
12/20/2024Saurabh SahaCEOSell55,000$17.44$959,200.00  
12/17/2024Karen M AndersonInsiderSell10,624$17.32$184,007.68  
12/17/2024Tia L BushCTOSell17,813$18.00$320,634.00  
12/16/2024Iqbal J HussainGeneral CounselSell77,705$16.39$1,273,584.95  
12/13/2024Karen M AndersonInsiderSell5,876$17.01$99,950.76  
12/6/2024Saurabh SahaCEOSell87,496$18.46$1,615,176.16  
11/25/2024Gregory M WeinhoffInsiderSell10,000$17.66$176,600.00  
11/25/2024Saurabh SahaCEOSell299$18.23$5,450.77  
11/22/2024Saurabh SahaCEOSell1,671$18.24$30,479.04  
11/20/2024Saurabh SahaCEOSell55,000$16.89$928,950.00  
10/25/2024Gregory M WeinhoffInsiderSell11,742$15.38$180,591.96  
10/23/2024Saurabh SahaCEOSell2,592$15.32$39,709.44  
10/21/2024Saurabh SahaCEOSell22,205$15.80$350,839.00  
9/25/2024Gregory M WeinhoffInsiderSell16,619$15.69$260,752.11  
9/20/2024Saurabh SahaCEOSell55,000$16.53$909,150.00  
(Data available from 1/1/2013 forward)

CNTA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Centessa Pharmaceuticals includes Antoine Yver, Arjun Goyal, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Karen M Anderson, Mario Alberto Accardi, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA.

7.09% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings.

The following insider purchased CNTA shares in the last 24 months: Arjun Goyal ($5,866,686.94).

Insiders have purchased a total of 462,585 CNTA shares in the last 24 months for a total of $5,866,686.94 bought.

The following insiders have sold CNTA shares in the last 24 months: David M Chao ($120,190.00), Gregory M Weinhoff ($2,250,793.09), Harris Rotman ($270,337.06), Iqbal J Hussain ($2,316,945.75), Karen M Anderson ($1,589,896.79), Mario Alberto Accardi ($476,744.06), Saurabh Saha ($12,898,377.11), and Tia L Bush ($1,551,934.00).

Insiders have sold a total of 1,355,106 Centessa Pharmaceuticals shares in the last 24 months for a total of $21,475,217.86 sold.

Centessa Pharmaceuticals Key Executives



This page (NASDAQ:CNTA) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners